Janocha, Reinhold
16  Ergebnisse:
Personensuche X
?
2

A Phase 3 Trial Analysis Proposal for Mitigating the Impact..:

Hua, Eva ; Janocha, Reinhold ; Severin, Thomas..
Statistics in Biopharmaceutical Research.  14 (2021)  1 - p. 80-86 , 2021
 
?
3

27362 High rate of complete response achieved with ligelizu..:

Bernstein, Jonathan A. ; Maurer, Marcus ; Giménez-Arnau, Ana...
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB137 , 2021
 
?
6

Ligelizumab is more effective in patients with chronic spon..:

Sitz, Karl ; Sussman, Gordon ; Metz, Martin...
Journal of Allergy and Clinical Immunology.  147 (2021)  2 - p. AB158 , 2021
 
?
7

25444 Ligelizumab further reduced sleep impairment in patie..:

Maurer, Marcus ; Sitz, Karl ; Sussman, Gordon...
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB58 , 2021
 
?
8

Long-term treatment with ligelizumab achieves prolonged sym..:

Soong, Weily ; Bernstein, Jonathan ; Sussman, Gordon...
Journal of Allergy and Clinical Immunology.  145 (2020)  2 - p. AB341 , 2020
 
?
11

Ligelizumab treatment for severe asthma: learnings from the..:

Trischler, Jordis ; Bottoli, Ivan ; Janocha, Reinhold...
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/63988.  , 2021
 
?
12

Sustained safety and efficacy of ligelizumab in patients wi..:

Maurer, Marcus ; Giménez Arnau, Anna Maria ; Bernstein, Jonathan A...
Maurer M, Giménez-Arnau A, Bernstein JA, Chu CY, Danilycheva I, Hide M, et al. Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: a one-year extension study. Allergy. 2022 Jul; 77(7): 2175-84. DOI:10.1111/all.15175.  ,
 
1-15